This article is more than 5 years old. Information may no longer be current.
Bioventus launches international headquarters in The Netherlands
Click Here to Manage Email Alerts
Bioventus launched its Dutch entity which coincides with the official opening of the company’s new International Headquarters in Hoofddorp, The Netherlands, according to a press release.
Formed earlier this year as a strategic partnership between Smith & Nephew and an Essex Woodlands led investor syndicate group, the launch of Smith & Nephew’s biologics and clinical therapies business in the Netherlands, including employees and products, has transitioned over to Bioventus. While Bioventus products delivered in the Netherlands will be rebranded from their current Smith & Nephew labels, the company said the product line will not change.
“The transition to Bioventus should be seamless for patients and healthcare providers who have relied on our innovative products and quality service over the years,” Mark Augusti, CEO of Bioventus, stated in a company press release. “Their sales contacts within our company will remain the same, as will our product portfolio. In fact, except for the rebranding of our organization and products, the only major change will be an increase in the level of support and product expertise we provide through our new, multilingual customer care center located in our international headquarters.”